Get started
Evaxion Biotech A/SEvaxion Biotech A/SEvaxion Biotech A/S

Evaxion Biotech A/S

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

EVAX chart


Full chart

EVAX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.98 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.9086 USD
Net income (FY)
‪−22.16 M‬ USD
Revenue (FY)
‪73.11 K‬ USD
Shares float
—
Beta (1Y)
0.38

About Evaxion Biotech A/S


Sector
Health Technology
Industry
Biotechnology
CEO
Christian Kanstrup
Website
evaxion-biotech.com
Headquarters
Hoersholm
Founded
2008
FIGI
BBG00YTSS733
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EVAX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.